[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU8505398A - Methods for enhancing or reducing preimplantation embryo survival rates - Google Patents

Methods for enhancing or reducing preimplantation embryo survival rates

Info

Publication number
AU8505398A
AU8505398A AU85053/98A AU8505398A AU8505398A AU 8505398 A AU8505398 A AU 8505398A AU 85053/98 A AU85053/98 A AU 85053/98A AU 8505398 A AU8505398 A AU 8505398A AU 8505398 A AU8505398 A AU 8505398A
Authority
AU
Australia
Prior art keywords
enhancing
reducing
methods
survival rates
preimplantation embryo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU85053/98A
Inventor
Abigail S. McElhinny
Carol M. Warner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NORTHEASTERN, University of
Original Assignee
NORTHEASTERN, University of
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NORTHEASTERN, University of filed Critical NORTHEASTERN, University of
Publication of AU8505398A publication Critical patent/AU8505398A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0604—Whole embryos; Culture medium therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C12N15/877—Techniques for producing new mammalian cloned embryos
    • C12N15/8775—Murine embryos
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0006—Modification of the membrane of cells, e.g. cell decoration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU85053/98A 1997-07-23 1998-07-22 Methods for enhancing or reducing preimplantation embryo survival rates Abandoned AU8505398A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5349997P 1997-07-23 1997-07-23
US60053499 1997-07-23
PCT/US1998/015124 WO1999005255A1 (en) 1997-07-23 1998-07-22 Methods for enhancing or reducing preimplantation embryo survival rates

Publications (1)

Publication Number Publication Date
AU8505398A true AU8505398A (en) 1999-02-16

Family

ID=21984712

Family Applications (1)

Application Number Title Priority Date Filing Date
AU85053/98A Abandoned AU8505398A (en) 1997-07-23 1998-07-22 Methods for enhancing or reducing preimplantation embryo survival rates

Country Status (2)

Country Link
AU (1) AU8505398A (en)
WO (1) WO1999005255A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ518163A (en) * 2002-04-05 2005-04-29 Kiwi Ingenuity Ltd Embryo modified with a glycolipid to enhance implantation into the endometrium
JP5456250B2 (en) 2004-03-22 2014-03-26 コード バイオテック リミテッド Synthetic molecular constructs and methods for altering cell surface antigen expression using the same
WO2007003033A1 (en) * 2005-06-17 2007-01-11 Mount Sinai Hospital Methods and compositions for enhancing developmental potential of oocytes and preimplantation embryos
US10271876B2 (en) 2011-11-23 2019-04-30 Mezadata Medical Ip Holding Llc Method of in vitro fertilization with delay of embryo transfer and use of peripheral blood mononuclear cells
EP2698636A1 (en) 2012-08-13 2014-02-19 Fundació Institut d'Investigació Biomèdica de Bellvitge Methods and reagents for prevention and/or treatment of transplant rejection
US10942184B2 (en) 2012-10-23 2021-03-09 Caris Science, Inc. Aptamers and uses thereof
CA2928520C (en) 2012-10-23 2023-03-14 Caris Life Sciences Switzerland Holdings, S.A.R.L. Aptamers and uses thereof
EP2935628B1 (en) 2012-12-19 2018-03-21 Caris Life Sciences Switzerland Holdings GmbH Compositions and methods for aptamer screening
WO2021078680A1 (en) * 2019-10-25 2021-04-29 Intellexon Gmbh Hla class i molecules in in vitro fertilization and further medical implications

Also Published As

Publication number Publication date
WO1999005255A1 (en) 1999-02-04

Similar Documents

Publication Publication Date Title
AU5430499A (en) Photobioreactor
AU3978199A (en) Multiconfiguration backplane
AU2077201A (en) Sperm quality assay
AU1809099A (en) Tool holding system
AU8505398A (en) Methods for enhancing or reducing preimplantation embryo survival rates
AU7142198A (en) Carbonation system
AU5450399A (en) Pestivirus vaccination
AU2656799A (en) Metal-thiols as imminomodulating agents
AU1080899A (en) Methods for increasing schwann cell survival
AU2739399A (en) Photobioreactor apparatus
AU3167497A (en) Enzymatic processes for preparing (s)-cyanohydrins
AU9399798A (en) Methods for regulating trka expression
AUPO060996A0 (en) Sexing gene
AU3834199A (en) Holder
AU2008399A (en) Method for cryopreserving oocytes
AU5791400A (en) Methods for improving the functional status of sperm
AU5846999A (en) Tray setting system
AU5525499A (en) Attachment apparatus
AU9153798A (en) Block carton
AUPR386101A0 (en) Culture system for embryos
AU3278399A (en) Edge-finishing apparatus
AU2300299A (en) Light-emitting medium for ornament
AU5296399A (en) Purification procedure for phenylhydrazines
AU2002242469A1 (en) Culture system for embryos
AUPO985697A0 (en) Multi-launcher for sonobuoys

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase